Cargando…

Role of direct immunofluorescence in dermatological disorders

BACKGROUND: Direct immunofluorescence (DIF) test for tissue-bound autoantibodies, has been found to be of value in the diagnosis of several dermatological disorders. The location and pattern of deposition of immunoreactants helps in classifying various immune-mediated diseases. AIMS AND OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales: Mysorekar, Vijaya V., Sumathy, T. K., Shyam Prasad, A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439745/
https://www.ncbi.nlm.nih.gov/pubmed/26009711
http://dx.doi.org/10.4103/2229-5178.156386
_version_ 1782372549129142272
author Mysorekar, Vijaya V.
Sumathy, T. K.
Shyam Prasad, A. L.
author_facet Mysorekar, Vijaya V.
Sumathy, T. K.
Shyam Prasad, A. L.
author_sort Mysorekar, Vijaya V.
collection PubMed
description BACKGROUND: Direct immunofluorescence (DIF) test for tissue-bound autoantibodies, has been found to be of value in the diagnosis of several dermatological disorders. The location and pattern of deposition of immunoreactants helps in classifying various immune-mediated diseases. AIMS AND OBJECTIVES: The aim of this study was to analyze the concordance between the clinical, histopathological and DIF diagnosis in bullous and nonbullous lesions of the skin, and thus determine the impact of immunofluorescence on diagnosis. MATERIALS AND METHODS: A total of 215 skin biopsies performed in suspected immune-mediated vesiculobullous disease, vasculitis or dermatosis, were studied. Histopathological examination was done along with DIF study for deposits of immunoglobulin G(IgG), IgA, IgM, and C3. RESULTS: Direct immunofluorescence was positive in 103/215 cases. There was very good concordance between the clinical, histological and DIF results (observed agreement = 93.4%, κ =0.90, with 95% confidence interval = 0.86–0.94). The overall sensitivity of DIF in immune-mediated skin disorders was 98.0%. DIF was positive in 52/53 cases (98.1%) in the pemphigus group and 24/25 (96.0%) bullous pemphigoid cases. None of the clinically suspected cases of dermatitis herpetiformis showed DIF positivity. A positive lupus band test was seen in 9/9 (100%) cases of lupus erythematosus. DIF was positive in 10/10 (100%) clinically suspected cases of Henoch–Schönlein purpura. In 110 cases, negative DIF results helped to rule out immune-mediated vesiculobullous disorders, lupus erythematosus and vasculitis, and the final diagnosis was made on the basis of the clinical features and/or histopathology. CONCLUSION: Direct immunofluorescence is a useful supplement for the accurate diagnosis of immune-mediated dermatological disorders, and helps to classify various autoimmune bullous disorders. When the clinical features/histopathology are inconclusive, the diagnosis often can be made on the basis of the DIF findings alone. A combination of the clinical features, histopathology and DIF usually gives the best results.
format Online
Article
Text
id pubmed-4439745
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44397452015-05-25 Role of direct immunofluorescence in dermatological disorders Mysorekar, Vijaya V. Sumathy, T. K. Shyam Prasad, A. L. Indian Dermatol Online J Original Article BACKGROUND: Direct immunofluorescence (DIF) test for tissue-bound autoantibodies, has been found to be of value in the diagnosis of several dermatological disorders. The location and pattern of deposition of immunoreactants helps in classifying various immune-mediated diseases. AIMS AND OBJECTIVES: The aim of this study was to analyze the concordance between the clinical, histopathological and DIF diagnosis in bullous and nonbullous lesions of the skin, and thus determine the impact of immunofluorescence on diagnosis. MATERIALS AND METHODS: A total of 215 skin biopsies performed in suspected immune-mediated vesiculobullous disease, vasculitis or dermatosis, were studied. Histopathological examination was done along with DIF study for deposits of immunoglobulin G(IgG), IgA, IgM, and C3. RESULTS: Direct immunofluorescence was positive in 103/215 cases. There was very good concordance between the clinical, histological and DIF results (observed agreement = 93.4%, κ =0.90, with 95% confidence interval = 0.86–0.94). The overall sensitivity of DIF in immune-mediated skin disorders was 98.0%. DIF was positive in 52/53 cases (98.1%) in the pemphigus group and 24/25 (96.0%) bullous pemphigoid cases. None of the clinically suspected cases of dermatitis herpetiformis showed DIF positivity. A positive lupus band test was seen in 9/9 (100%) cases of lupus erythematosus. DIF was positive in 10/10 (100%) clinically suspected cases of Henoch–Schönlein purpura. In 110 cases, negative DIF results helped to rule out immune-mediated vesiculobullous disorders, lupus erythematosus and vasculitis, and the final diagnosis was made on the basis of the clinical features and/or histopathology. CONCLUSION: Direct immunofluorescence is a useful supplement for the accurate diagnosis of immune-mediated dermatological disorders, and helps to classify various autoimmune bullous disorders. When the clinical features/histopathology are inconclusive, the diagnosis often can be made on the basis of the DIF findings alone. A combination of the clinical features, histopathology and DIF usually gives the best results. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4439745/ /pubmed/26009711 http://dx.doi.org/10.4103/2229-5178.156386 Text en Copyright: © Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mysorekar, Vijaya V.
Sumathy, T. K.
Shyam Prasad, A. L.
Role of direct immunofluorescence in dermatological disorders
title Role of direct immunofluorescence in dermatological disorders
title_full Role of direct immunofluorescence in dermatological disorders
title_fullStr Role of direct immunofluorescence in dermatological disorders
title_full_unstemmed Role of direct immunofluorescence in dermatological disorders
title_short Role of direct immunofluorescence in dermatological disorders
title_sort role of direct immunofluorescence in dermatological disorders
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439745/
https://www.ncbi.nlm.nih.gov/pubmed/26009711
http://dx.doi.org/10.4103/2229-5178.156386
work_keys_str_mv AT mysorekarvijayav roleofdirectimmunofluorescenceindermatologicaldisorders
AT sumathytk roleofdirectimmunofluorescenceindermatologicaldisorders
AT shyamprasadal roleofdirectimmunofluorescenceindermatologicaldisorders